Craig McGlashan
Private equity bets on snacks.
Main Post invests in a franchisee operator.
CenterOak Partners sells CollisionRight to Summit Partners.
Galakatos says 'the most important current breakthrough in science is our increasing ability to practise precision medicine based on our understanding of the human genome.'
MPearlRock goes bullish over retail.
General Atlantic moves for sustainable infrastructure firm Actis; S&P Global Market Intelligence confirms what we already knew – that 2023 had a big drop-off in dealmaking; new pharma deals from Vesey Street Capital and Aquiline Capital; Battery Ventures' majority investment in a decision-support software and data science company.
L2 acquires a basketball floor manufacturer Robbins.
Platinum Equity is acquiring Horizon Organic, an organic milk producer.
Bridgepoint is reinvesting in PEI.
'Our initial investment in 2018 via our small mid-cap fund has been highly successful and we’re delighted that Bridgepoint will be able to continue working with management and provide additional investment for the next stage of growth of PEI,' says Bridgepoint.